Cargando…

Impact of Gonadotropin-Releasing Hormone Agonist Pre-treatment on the Cumulative Live Birth Rate in Infertile Women With Adenomyosis Treated With IVF/ICSI: A Retrospective Cohort Study

Introduction: Although pre-treatment with a GnRH agonist can reduce the size of adenomyosis lesions, the supra-physiological hormone level induced by controlled ovarian hyperstimulation (COH) may negate the usefulness of the GnRH agonist in patients with adenomyosis lesions, leading to continued poo...

Descripción completa

Detalles Bibliográficos
Autores principales:	Chen, Minghui, Luo, Lu, Wang, Qiong, Gao, Jun, Chen, Yuqing, Zhang, Yingying, Zhou, Canquan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2020
Materias:	Endocrinology
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273842/ https://www.ncbi.nlm.nih.gov/pubmed/32547490 http://dx.doi.org/10.3389/fendo.2020.00318

Ejemplares similares

Impact of adenomyosis and endometriosis on IVF/ICSI pregnancy outcome in patients undergoing gonadotropin-releasing hormone agonist treatment and frozen embryo transfer
por: Wang, Yu, et al.
Publicado: (2023)

Short versus Long Gonadotropin-Releasing Hormone Analogue Suppression Protocols in IVF/ICSI Cycles in Patients of Various Age Ranges
por: Ou, Jianping, et al.
Publicado: (2015)

Half-dose, long-acting gonadotropin-releasing hormone agonist (Diphereline) is comparable with daily injections of short-acting gonadotropin-releasing hormone agonist (Suprefact) in IVF/ICSI cycles
por: Tehraninejad, Ensieh Sh., et al.
Publicado: (2010)

Can repeat IVF/ICSI cycles compensate for the natural decline in fertility with age? an estimate of cumulative live birth rates over multiple IVF/ICSI cycles in Chinese advanced-aged population
por: Gu, Fang, et al.
Publicado: (2021)

Gonadotrophin releasing hormone antagonist in IVF/ICSI
por: MS, Kamath, et al.
Publicado: (2008)

Comparison of Cumulative Live Birth Rate Between Aged PCOS Women and Controls in IVF/ICSI Cycles
por: Mai, Zhuoyao, et al.
Publicado: (2021)

Dyslipidemia Is Negatively Associated With the Cumulative Live-Birth Rate in Patients Without PCOS Following IVF/ICSI
por: Liu, Zhenteng, et al.
Publicado: (2021)

IVF and ICSI in Male Infertility: Update on Outcomes, Risks, and Costs
por: Karpman, Edward, et al.
Publicado: (2005)

Evaluation of the impact of gonadotropin-releasing hormone agonist as an adjuvant in luteal-phase support on IVF outcome
por: Inamdar, Dattaprasad B, et al.
Publicado: (2012)

Endometriosis does not seem to be an influencing factor of hypertensive disorders of pregnancy in IVF / ICSI cycles
por: Lee, Pingyin, et al.
Publicado: (2022)

Ultra-Long GnRH Agonist Protocol During IVF/ICSI Improves Pregnancy Outcomes in Women With Adenomyosis: A Retrospective Cohort Study
por: Lan, Jie, et al.
Publicado: (2021)

Analysis of IVF/ICSI Outcomes in Endometriosis Patients With Recurrent Implantation Failure: Influence on Cumulative Live Birth Rate
por: Zhong, Chenyi, et al.
Publicado: (2021)

Effects of artificial cycles with and without gonadotropin-releasing hormone agonist pretreatment on frozen embryo transfer outcomes in patients with adenomyosis
por: Li, Muzi, et al.
Publicado: (2021)

Cumulative live birth rates and birth outcomes after IVF/ICSI treatment cycles in young POSEIDON patients: A real-world study
por: Yan, Enqi, et al.
Publicado: (2023)

Adverse Outcomes of IVF/ICSI Pregnancies Vary Depending on Aetiology of Infertility
por: Kuivasaari-Pirinen, Paula, et al.
Publicado: (2012)

Predicting cumulative live birth rate for patients undergoing in vitro fertilization (IVF)/intracytoplasmic sperm injection (ICSI) for tubal and male infertility: a machine learning approach using XGBoost
por: Chen, Zhiyan, et al.
Publicado: (2022)

Live Birth and Cumulative Live Birth Rates in Expected Poor Ovarian Responders Defined by the Bologna Criteria Following IVF/ICSI Treatment
por: Chai, Joyce, et al.
Publicado: (2015)

A randomized controlled trial of gonadotropin-releasing hormone agonist versus gonadotropin-releasing hormone antagonist in Iranian infertile couples: oocyte gene expression
por: Hoseini, Fatemeh Sadat, et al.
Publicado: (2014)

High Serum Anti-Müllerian Hormone Concentrations Are Associated With Poor Pregnancy Outcome in Fresh IVF/ICSI Cycle but Not Cumulative Live Birth Rate in PCOS Patients
por: Guo, Yaxin, et al.
Publicado: (2021)

Pregnancy rate in women with adenomyosis undergoing fresh or frozen embryo transfer cycles following gonadotropin-releasing hormone agonist treatment
por: Park, Chan Woo, et al.
Publicado: (2016)

Correction: Live Birth and Cumulative Live Birth Rates in Expected Poor Ovarian Responders Defined by the Bologna Criteria Following IVF/ICSI Treatment
por: Chai, Joyce, et al.
Publicado: (2015)

Can we predict the IVF/ICSI live birth rate?
por: Metello, José Luis, et al.
Publicado: (2019)

Risk factors associated with preterm birth after IVF/ICSI
por: Li, Jian, et al.
Publicado: (2022)

Health-related quality of life in infertile couples receiving IVF or ICSI treatment
por: Rashidi, Batool, et al.
Publicado: (2008)

ICSI Does Not Improve Live Birth Rates but Yields Higher Cancellation Rates Than Conventional IVF in Unexplained Infertility
por: Song, Jianyuan, et al.
Publicado: (2021)

Efficacy of Combined Levonorgestrel-Releasing Intrauterine System with Gonadotropin-Releasing Hormone Analog for the Treatment of Adenomyosis
por: Zhang, Peihai, et al.
Publicado: (2013)

Medroxyprogesterone Acetate versus Gonadotropin-Releasing Hormone Antagonist for the Prevention of Premature Luteinizing Hormone Surge in hyper-responder women undergoing controlled ovarian stimulation for IVF/ICSI Cycles
por: Tandulwadkar, Sunita, et al.
Publicado: (2023)

Infertility and Adenomyosis
por: Campo, Sebastiano, et al.
Publicado: (2012)

Stress, anxiety, and depression in infertile couples are not associated with a first IVF or ICSI treatment outcome
por: Peng, Meijuan, et al.
Publicado: (2021)

Correlation between saliva and serum concentrations of estradiol in women undergoing ovarian hyperstimulation with gonadotropins for IVF/ICSI
por: Dielen, C, et al.
Publicado: (2017)

Cumulative live-birth, perinatal and obstetric outcomes for POSEIDON groups after IVF/ICSI cycles: a single-center retrospective study
por: Abdullah, Raed K., et al.
Publicado: (2020)

IVF or ICSI for fertility preservation?
por: Aggarwal, Bhorika, et al.
Publicado: (2021)

Gonadotropin releasing hormone agonists: Expanding vistas
por: Magon, Navneet
Publicado: (2011)

The Effects of Adiponectin on Infertile Women Undergoing IVF/ICSI Treatment and on Human Granulosa Cells
por: Qin, Lixian, et al.
Publicado: (2021)

Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI
por: Piette, Paul C M
Publicado: (2021)

Serum levels of cancer antigen 125 before hormone replacement therapy are not associated with clinical outcome of frozen embryo transfer in women with adenomyosis
por: Huang, Ling, et al.
Publicado: (2021)

Association Between Uterine Volume and In Vitro Fertilization (IVF) Reproductive Outcomes of Infertile Patients with Adenomyosis
por: Zhang, Wen, et al.
Publicado: (2023)

A pilot study to search possible mechanisms of ultralong gonadotropin-releasing hormone agonist therapy in IVF-ET patients with endometriosis
por: Tamura, Hiroshi, et al.
Publicado: (2014)

Reply: Questionable recommendation for LPS for IVF/ICSI in ESHRE guideline 2019: ovarian stimulation for IVF/ICSI
por: Broekmans, Frank, et al.
Publicado: (2021)

Evaluation of Dysfunctional HDL by Myeloperoxidase/Paraoxonase Ratio in Unexplained Infertility Patients Undergoing IVF/ICSI
por: Erdoğan, Kadriye, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_t8di8e93sjpdp07ba7sfikupje